# US 2014/0271454 A1 · Cell-synthesized particles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0271454 A1
- Document ID: US20140271454A1
- Status: Published application
- Kind: A1
- Application number: 14/113,060
- Filed: 2012-04-23
- Published: 2014-09-18
- Earliest claimed: 2011-04-21
- Assignees: Cytograft Tissue Engineering, Inc.
- Inventors: Nicolas L'Heureux; Todd N McAllister
- Web page: https://patentgrep.com/patent/US20140271454A1

## CPC

- A61L 27/3633: {Extracellular matrix [ECM]}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61L 27/3691: {characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation}
- C12N 5/0062: {General methods for three-dimensional culture}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present technology provides for a cell-synthesized biological particle, the processes for making a cell-synthesized particle, and a process for assembling such cell-synthesized particles into tissues and organs. The particles are synthesized in culture in vitro by living cells that produce natural extracellular matrix. Multiple particles can be assembled into tissues that have significant void space. The particles or tissues can act as a substrate for additional cell types. The particles or tissues can be further cultured in vitro to achieve favorable cell or extracellular matrix growth, organization or other desired characteristics. The particles or tissues can be devitalized or decellularized. The particles or tissues can be injected or implanted in a human to repair, enhance, or create a secretory, mechanical, or aesthetic function.

## Claims

### Claim 1

A composition comprising one or more tissue engineered particles, the particles comprising one or more biological cells and an extracellular matrix synthesized by the cells.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the biological cells comprise two or more cell types.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the cells have been substantially devitalized.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the cells have been genetically engineered.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the particle has a diameter from about 50 micrometers to about 5 mm.

### Claim 6 (depends on 1)

The composition of claim 1, further comprising an exogenous component.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the exogenous component is a natural or synthetic constituent selected from: peptides, proteins, glycoproteins, proteoglycans, antibodies, polysaccharides, DNA or RNA, transfection agents, antibiotics, pharmaceutical agents, metal particles, insoluble mineral crystals or particles, polymer particles, radioactive agents, drug delivery systems, or radio-frequency identification chips or other magnetic or electronic devices.

### Claim 8

A method of making a tissue engineered particle composition, the method comprising:
(a) seeding a population of cells in a culture vessel;
(b) culturing the cells under conditions that allow the formation of a tissue sheet in contact with an inner surface of the culture vessel, wherein the sheet is comprised of cells and extracellular matrix synthesized by the cells; and
(c) cutting the sheet into a plurality of pieces thereby forming a particle composition.

### Claim 9 (depends on 8)

The method of claim 8, wherein the cells comprise one or more types of cell selected from: fibroblasts, stromal cells, myofibroblasts, myocytes or their precursors, smooth muscle cells or their precursors, macrophages, osteoblasts or their precursors, mesenchymal stem cells, bone marrow-derived stem cells, fat-derived stem cells, skin-derived stem cells (including appendages), embryonic stem cells, induced pluripotent stem cells or a combination thereof.

### Claim 10 (depends on 8)

The method of claim 8, wherein the population of cells has been genetically engineered.

### Claim 11 (depends on 8)

The method of claim 8, further comprising detaching the plurality of pieces from the substrate.

### Claim 12 (depends on 8)

The method of claim 8, further comprising removing the tissue sheet from the substrate before the cutting.

### Claim 13 (depends on 8)

The method of claim 8, wherein the area of each of the pieces is from about 0.01 mm2 to about 400 mm2.

### Claim 14 (depends on 8)

The method of claim 8, further comprising substantially devitalizing the tissue sheet or the biocompatible particle composition.

### Claim 15 (depends on 8)

The method of claim 8, further comprising:
(i) culturing the adherent cells in the presence an exogenous component; or
(ii) associating an exogenous component with the tissue sheet or the formed particle composition.

### Claim 16 (depends on 8)

The method of claim 8, further comprising treating the tissue sheet or the particle composition with a cross-linking agent.

### Claim 17 (depends on 8)

The method of claim 8, further comprising drying the tissue sheet before cutting.

### Claim 18

A method of making a tissue-engineered construct, the method comprising:
(a) placing one or more types of cell-synthesized particle compositions in a container;
(b) culturing the particles under conditions that allow the fusion of the particles, thereby forming a tissue; and
(c) shaping the tissue into a construct.

### Claim 19 (depends on 18)

The method of claim 18, further comprising partially devitalizing the construct.

### Claim 20 (depends on 18)

The method of claim 18, further comprising seeding one or more cells in or on the tissue.

### Claim 21 (depends on 8, 18)

The method of claim 18, wherein the cell-synthesized particles are made by the method of claim 8.

### Claim 22 (depends on 1)

The composition of claim 1 in a form suitable for injection.
